ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Real-world safety profile of eravacycline compared with tigecycline, minocycline, and meropenem: a comparative pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS).

Yan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.